OxStem

OxStem

OxStem

OxStem is a drug discovery company, spunout from the University of Oxford, with the unique vision of developing insitu cell programming therapies to treat what are typically (but certainly not exclusively) agerelated conditions, such as Dementia, Heart Fa
Founded
2013
Raised
$24.9M
Follow us
Alexa global traffic share
Latest funding
£16,900,000
Venture capital (Series UNDISCLOSED) - 2016
Team Size
2
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when OxStem makes some noise.